Lab Automation Market

The global lab automation market is expected to grow from USD 6.60 billion in 2026 to USD 8.62 billion by 2031, representing a CAGR of 6.6%. The lab automation market is driven by several key factors, including the growing demand for high-throughput screening and a shortage of qualified laboratory personnel. Automation can enhance laboratory efficiency by delivering accurate results while lowering operational costs. Significant advancements in this field are centered around artificial intelligence, robotics, and machine learning. Other influences on the market include the rising incidence of chronic diseases and the increased demand for personalized medicine. By adopting automation, laboratories can handle larger patient samples, enabling quicker and more precise diagnoses.

The lab automation market is highly competitive and characterized by continuous innovation. Key competitive factors include the development of automated high-throughput systems, the integration of artificial intelligence and data analytics, and improvements in accuracy, reliability, and speed. Companies are heavily investing in research and development to enhance their products and maintain a competitive edge, contributing to the ongoing growth of the lab automation market. Market leaders are continuously expanding their product offerings to meet the evolving needs of laboratories in sectors such as diagnostics, pharmaceuticals, and biotechnology.

To know about the assumptions considered for the study download the pdf brochure

Some of the key players in the lab automation market include Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), bioMérieux (France), Hamilton Company (US), and Hudson Robotics (US).

Thermo Fisher Scientific, Inc. (US) is a prominent player in the lab automation market, known for offering a wide range of analytical equipment, reagents, consumables, laboratory equipment, and software & services. It has a global presence, operating in over 50 countries across North America, Europe, Asia Pacific, and Latin America. The firm provides a range of lab automation products, including automated liquid-handling systems, automated ELISA systems, automated nucleic acid extraction kits, laboratory robotic systems, mobile robots, laboratory data management solutions, microplate readers, multidrop dispensers, and microplate washers. These products are offered through its Analytical Instruments and Laboratory Products & Biopharma Services segment. Additionally, the company engages in strategic acquisitions to strengthen its market presence. For example, in October 2023, it acquired Olink Holding AB in Sweden to enhance its capabilities in proteomics.

Tecan Group (Switzerland) is a leader in lab automation, specializing in the development of robotic sample processors, detection devices, laser scanners, integrated systems, and pumps and valves for high-precision liquid handling. The company has manufacturing and research and development (R&D) facilities in North America and Europe, and it operates its services in over 52 countries. Tecan's core products include microplate readers and washers, liquid handling and automation solutions, robotic arms, nucleic acid purification systems, automated ELISA systems, and software. The company operates through two main business segments: Life Sciences and Partnering. A recent development is the launch of the Resolvex i1300 in February 2024, which is a component of the Fluent automation workstation. This new product supports proteomics workflows and can be applied to biomarker discovery, drug development, and personalized medicine.

Danaher Corporation (US) is a leading player in the laboratory automation market, specializing in the design, development, and marketing of medical, industrial, and commercial products. The company operates 93 facilities in the US and 119 sites across 30 other countries. Its lab automation products include microplate readers, DNA extraction kits, liquid handlers, clinical laboratory diagnostic products, and software, all provided through its life sciences business segment. In August 2024, Danaher acquired Genedata, a Swiss company, to incorporate Genedata's life sciences software solutions into its product portfolio.

Agilent Technologies (US) specializes in the design, manufacturing, and delivery of products and services within its diagnostics, life sciences, and applied chemicals divisions. As an international organization, it operates globally across the Americas, Europe, the Middle East and Africa, and Asia/Pacific. The company has production and R&D facilities located in Australia, China, Germany, Italy, Malaysia, Singapore, the UK, and the US. Among the lab automation systems offered by this company are Automated Liquid Handling Systems, Microplate Readers, Microplate Washers and Dispensers, Microplate Stackers and Incubators, Microplate Automation Software, and Software & Informatics. In its Life Sciences and Applied Markets segment, Agilent provides an array of lab automation products. Notably, in January 2024, Agilent launched the ProteoAnalyzer, an automated system for parallel capillary electrophoresis in proteomics.

F. Hoffmann-La Roche Ltd. (Switzerland) is a leading player in the lab automation market, with a global presence in North America, Europe, Latin America, Africa, and Asia. The company operates through two main business segments: Pharmaceuticals and Diagnostics. Within the Diagnostics segment, Roche provides workflow solutions and lab automation solutions.

Related Reports:

Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, Workcell, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, HTS), End User (Pharma, Forensic, Environmental, Diagnostic Lab)Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]